NCT00576641View on ClinicalTrials.gov

Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

January 31, 2010

Study Completion Date

April 30, 2012

Conditions
Brain Stem GliomaGlioblastoma
Interventions
BIOLOGICAL

autologous dendritic cells

Trial Locations (1)

90048

Cedars Sinai Medical Center, Los Angeles

All Listed Sponsors
lead

Cedars-Sinai Medical Center

OTHER

NCT00576641 - Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma | Biotech Hunter | Biotech Hunter